Research Article
Effectiveness of an Inpatient Movement Disorders Program for Patients with Atypical Parkinsonism
Table 1
Patient baseline characteristics.
| | Characteristic | |
| | Age—y, mean (SD) | 76.6 (7.7) | | Disease duration—y, mean (SD) | 5.7 (4.4) | | Sex no. (%) men/women | 53 (58.2)/38 (41.8) | | Race no. (%) white | 84 (92.3) | | Education no. (%) ≤ bachelor’s/>bachelor’s | 51 (56)/24 (26.4) | | Hoehn and Yahr stage no. (%) | | | I | 0 (0) | | II | 0 (0) | | III | 26 (28.6) | | IV | 43 (47.3) | | V | 16 (17.6) | | Length of stay—d, mean (SD) | 24.4 (11.9) |
| | Diagnosis no. (%) a | | | Vascular parkinsonism | 25 (27.5) | | MSA | 19 (20.9) | | PSP | 4 (4.4) | | Medication related | 2 (2.2) | | LBD | 1 (1.1) | | CBD | 1 (1.1) | | Toxin | 1 (1.1) | | Unknown | 38 (41.8) |
|
|
aMSA: multiple system atrophy, PSP: progressive supranuclear palsy, LBD: Lewy body dementia, and CBD: corticobasal dementia.
|
